Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating Tolerability of ePUHRT With Brachytherapy Boost
Sponsor: Indiana University
Summary
The purpose of this study is to evaluate the tolerability and toxicity of combining two radiation therapy methods for prostate cancer: Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is an external beam radiotherapy with High Dose Rate Brachytherapy Boost (form of internal radiation where a cancer doctor implants a small plastic tube or balloon (catheter) in the tumor).
Official title: Evaluating Tolerability of Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT) With High Dose Rate Brachytherapy Boost for Unfavorable and Higher Risk Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
31
Start Date
2025-03-05
Completion Date
2028-10
Last Updated
2025-09-26
Healthy Volunteers
No
Conditions
Interventions
ePURT 5Gy x 5 fractions with single HDR boost of 15Gy
ePURT 5Gy x 5 fractions delivered on noncontiguous weekdays with single HDR boost of 15Gy.
Locations (1)
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States